ریلپی‌ویرین (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "ریلپی‌ویرین" in Persian language version.

refsWebsite

Global rank Persian rank

68^th place

179^th place

4^th place

5^th place

2web.archive.org

1^st place

1^st place

1medicines.org.uk

3,823^rd place

1,188^th place

low place

low place

2^nd place

2^nd place

1semanticscholar.org

11^th place

52^nd place

1retroconference.org

low place

low place

doi.org (Global: 2^nd place; Persian: 2^nd place)

Goebel F, Yakovlev A, Pozniak AL, Vinogradova E, Boogaerts G, Hoetelmans R, et al. (August 2006). "Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects". AIDS. 20 (13): 1721–1726. doi:10.1097/01.aids.0000242818.65215.bd. PMID 16931936. S2CID 26078073.

europa.eu (Global: 68^th place; Persian: 179^th place)

ema.europa.eu

"Edurant EPAR". آژانس دارویی اروپا (EMA). Retrieved 4 January 2021.
"Vocabria: EPAR – Product information" (PDF). European Medicines Agency. 2021-01-05.
"Rekambys: EPAR – public assessment report" (PDF). European Medicines Agency. 2021-02-22.
"Edurant: EPAR – public assessment report" (PDF). European Medicines Agency. 2021-01-04.

medicines.org.uk (Global: 3,823^rd place; Persian: 1,188^th place)

"Edurant 25 mg tablets - Summary of Product Characteristics (SmPC)". (emc). 21 January 2020. Retrieved 4 January 2021.

nih.gov (Global: 4^th place; Persian: 5^th place)

pubmed.ncbi.nlm.nih.gov

Stellbrink HJ (October 2007). "Antiviral drugs in the treatment of AIDS: what is in the pipeline ?". European Journal of Medical Research. 12 (9): 483–495. PMID 17933730.
Goebel F, Yakovlev A, Pozniak AL, Vinogradova E, Boogaerts G, Hoetelmans R, et al. (August 2006). "Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects". AIDS. 20 (13): 1721–1726. doi:10.1097/01.aids.0000242818.65215.bd. PMID 16931936. S2CID 26078073.

dailymed.nlm.nih.gov

"Edurant- rilpivirine hydrochloride tablet, film coated". DailyMed. Retrieved 4 January 2021.

retroconference.org (Global: low place; Persian: low place)

Pozniak A, Morales-Ramirez J, Mohap L, et al. "48-Week Primary Analysis of Trial TMC278-C204: TMC278 Demonstrates Potent and Sustained Efficacy in ART-naïve Patients. Oral abstract 144LB". 14th Conference on Retroviruses and Opportunistic Infections. Archived from the original on October 19, 2007.

semanticscholar.org (Global: 11^th place; Persian: 52^nd place)

api.semanticscholar.org

Goebel F, Yakovlev A, Pozniak AL, Vinogradova E, Boogaerts G, Hoetelmans R, et al. (August 2006). "Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects". AIDS. 20 (13): 1721–1726. doi:10.1097/01.aids.0000242818.65215.bd. PMID 16931936. S2CID 26078073.

tibotec.com (Global: low place; Persian: low place)

"TMC278 — A new NNRTI". Tibotec. Archived from the original on 2008-12-20. Retrieved 2010-03-07.

web.archive.org (Global: 1^st place; Persian: 1^st place)

"TMC278 — A new NNRTI". Tibotec. Archived from the original on 2008-12-20. Retrieved 2010-03-07.
Pozniak A, Morales-Ramirez J, Mohap L, et al. "48-Week Primary Analysis of Trial TMC278-C204: TMC278 Demonstrates Potent and Sustained Efficacy in ART-naïve Patients. Oral abstract 144LB". 14th Conference on Retroviruses and Opportunistic Infections. Archived from the original on October 19, 2007.